New device could keep donor hearts alive longer outside the body

NCT ID NCT06035991

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a device that keeps donor hearts alive outside the body for longer periods before transplant. The goal is to see if hearts preserved this way work well within 15 days after surgery. Twenty adults with severe heart failure who cannot get a standard transplant are participating.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ex-vivo heart perfusion device
What this could lead to
If successful, this could allow donor hearts to be preserved for longer periods, potentially increasing the number of hearts available for transplant.
What could go wrong
This is a very early, small trial with only 20 participants. The device may not work as hoped, and there are always risks with any transplant surgery, including organ rejection or failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pitié-Salpêtrière Hospital

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.